(-0.41%) 5 460.48 points
(-0.12%) 39 119 points
(-0.71%) 17 733 points
(-0.34%) $81.46
(-3.13%) $2.60
(0.01%) $2 336.90
(0.61%) $29.44
(0.28%) $1 009.00
(-0.06%) $0.933
(0.45%) $10.68
(-0.05%) $0.791
(0.86%) $85.73
Live Chart Being Loaded With Signals
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally...
Stats | |
---|---|
Šios dienos apimtis | 387 776 |
Vidutinė apimtis | 677 842 |
Rinkos kapitalizacija | 843.96M |
EPS | $-0.200 ( Q2 | 2023-02-09 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-20.83 (Sector) 42.63 (Industry) 0 |
ATR14 | $0.103 (0.52%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-04-27 | Paulsen Erik | Sell | 20 627 | Restricted Stock Units |
2023-04-27 | Paulsen Erik | Sell | 700 | Common Stock |
2023-04-27 | Points Jeffrey S. | Sell | 138 957 | Common Stock |
2023-04-27 | Points Jeffrey S. | Sell | 34 051 | Common Stock |
2023-04-27 | Rempe Stephen J. | Sell | 75 659 | Common Stock |
INSIDER POWER |
---|
-86.53 |
Last 100 transactions |
Buy: 675 433 | Sell: 1 911 221 |
Tūris Koreliacija
Cardiovascular Systems Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Cardiovascular Systems Koreliacija - Valiuta/Žaliavos
Cardiovascular Systems Finansinės ataskaitos
Annual | 2022 |
Pajamos: | $236.22M |
Bruto pelnas: | $172.78M (73.14 %) |
EPS: | $-0.940 |
FY | 2022 |
Pajamos: | $236.22M |
Bruto pelnas: | $172.78M (73.14 %) |
EPS: | $-0.940 |
FY | 2021 |
Pajamos: | $258.97M |
Bruto pelnas: | $197.84M (76.39 %) |
EPS: | $-0.350 |
FY | 2020 |
Pajamos: | $236.55M |
Bruto pelnas: | $187.79M (79.39 %) |
EPS: | $-0.790 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Cardiovascular Systems
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Coronary orbital atherectomy systems (OAS), a coronary artery disease (CAD) product designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to severely calcified coronary artery lesions. In addition, it offers guidewires, catheters, balloons, embolic protection system, and other OAS support products. Cardiovascular Systems, Inc. has a partnership with Chansu Vascular Technologies, LLC to develop novel peripheral and coronary everolimus drug-coated balloons. The company was formerly known as Shturman Cardiology Systems, Inc. and changed its name to Cardiovascular Systems, Inc. in January 2003. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in Saint Paul, Minnesota.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.